Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
34.17
-1.14 (-3.23%)
At close: Jul 2, 2024, 4:00 PM
34.16
-0.01 (-0.03%)
After-hours: Jul 2, 2024, 7:05 PM EDT
BHVN Market Cap
BHVN has a market cap or net worth of $3.02 billion as of July 2, 2024. Its market cap has increased by 95.66% in one year.
Market Cap
3.02B
Enterprise Value
2.76B
1-Year Change
95.66%
Ranking
Category
Stock Price
$34.17
Market Cap Chart
Since October 4, 2022, BHVN's market cap has increased from $297.30M to $3.02B, an increase of 914.78%. That is a compound annual growth rate of 277.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 3.02B | -12.15% |
| Dec 29, 2023 | 3.43B | 262.96% |
| Dec 30, 2022 | 946.10M | 218.23% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.31B |
| Arrowhead Pharmaceuticals | 3.23B |
| Oscar Health | 3.19B |
| Olink Holding AB (publ) | 3.17B |
| PROCEPT BioRobotics | 3.14B |
| Surgery Partners | 3.02B |
| Amedisys | 3.00B |
| HUTCHMED (China) | 2.98B |